That study suggests that the disruption of circadian gene (DEC1 and DEC2) expression in major depressive disorder may affect regulating mood; consequently, DEC1 and DEC2 might serve as potential molecular targets for mood disorder treatments [86]. This evidence concerns the gene BHLHE41 and major depressive disorder.